New 3-in-1 solution!

Comply with the ISSCR standards with our new 3-in-1 service: digital karyotyping, STR & mycoplasma testing from one sample in just 3 days! Send DNA in the post and we’ll take it from there.

genomic abnormalities

We help you improve your confidence in the genomic stability of your human cell lines so you gain time, credibility and quality in your final product. Strengthen your workflow with a cost-effective solution.

Target genomic abnormalities in human stem cells

Expand your knowledge

Our Next-Generation Sequencing (NGS) range of assays has been designed with the needs of stem cell research scientists in mind. Get a clear and meaningful interpretation catered to your needs. 

Expand your genomic knowledge

Ensure consistent cell identity throughout your culture process. Our easy and fast STR-profiling service will help you detect any potential mislabelling or cross contaminations in the laboratory.

Short Tandem Repeat

Next generation quality control for cell therapy

Stem Genomics is a biotech company specialized in the development of innovative testing solutions for research scientists working on human stem cells. We help you assess the genomic stability of your cell lines with specific assays and recommended workflows for the cell type you work with.

Whether you work on Pluripotent Stem Cells (PSCs), Mesenchymal Stromal Cells (MSCs) or other types of human stem cells, we can perform various categories of tests and analyses suited to your specific needs.

Discover a range of straightforward tests dedicated to your cell type

Our flagship testing solution, digital PCR-based assay iCS-digital™ PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. We can also perform the following tests for you: G-Banding karyotyping, mycoplasma detection, STR (Short Tandem Repeat), aneuploidy detection, Next Generation Sequencing or design customized assays to meet your requirements. 

All our tests will take into account the constraints related to the cell type you work with. With all the assays we perform, you will receive clear, straightforward reports to make it easier to understand the analysis and to support your decision-making process.

Benefit from our experience and expertise in stem cells

Founded in 2018, Stem Genomics is a spin-out of the Institute for Regenerative Medicine & Biotherapy (IRMB), co-founded by Professor John de Vos and Dr. Said Assou, experts in stem cell genomic integrity. To date, we have worked with over 150 clients worldwide.

Upcoming webinar

Join us LIVE for our webinar “Genomic stability made easy” to discover how Stem Genomics has turned cutting-edge technologies into easy testing solutions accessible to most labs.

Get expert opinions and user perspectives on our genomic stability assays in the context of iPSC research.

Happening on Tuesday, November 14, 6 pm CET

Download this file immediately

Please enter your e-mail address.